C1q/TNF-related protein-9 inhibits cytokine-induced vascular inflammation and leukocyte adhesiveness via AMP-activated protein kinase activation in endothelial cells

Molecular and Cellular Endocrinology

Volumn 419, Issue , 2016, Pages 235-243

  Jung, Chang Hee ^a   Lee, Min Jung ^a   Kang, Yu Mi ^a   Lee, Yoo La ^a   Seol, So Mi ^a   Yoon, Hae Kyeong ^a   Kang, Sang Wook ^a   Lee, Woo Je ^a   Park, Joong Yeol ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Adhesion molecules; AMPK; CTRP9; Endothelial cells; NF B

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADIPOCYTOKINE; C1Q TNF RELATED PROTEIN 9; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; ADIPONECTIN; C1QTNF9B PROTEIN, HUMAN; CCL2 PROTEIN, HUMAN; GLYCOPROTEIN;

AORTA ENDOTHELIUM; ARTICLE; CELL ADHESION ASSAY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULITIS; AORTA; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; AORTA; CELL LINE, TUMOR; CHEMOKINE CCL2; CYTOKINES; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; NF-KAPPA B; PHOSPHORYLATION; SIGNAL TRANSDUCTION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84949599369     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.10.023     Document Type: Article

References (38)

1. Bess E., Fisslthaler B., Fromel T., Fleming I. Nitric oxide-induced activation of the AMP-activated protein kinase alpha2 subunit attenuates IkappaB kinase activity and inflammatory responses in endothelial cells. PLoS One 2011, 6:e20848.
2. Blankenberg S., Barbaux S., Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003, 170:191-203.
3. Bluher M. Clinical relevance of adipokines. Diabetes Metab. J. 2012, 36:317-327.
4. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998, 394:894-897.
5. Bourcier T., Sukhova G., Libby P. The nuclear factor kappa-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J. Biol. Chem. 1997, 272:15817-15824.
6. Brand K., Page S., Rogler G., Bartsch A., Brandl R., Knuechel R., Page M., Kaltschmidt C., Baeuerle P.A., Neumeier D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J. Clin. Investig. 1996, 97:1715-1722.
7. Brand K., Page S., Walli A.K., Neumeier D., Baeuerle P.A. Role of nuclear factor-kappa B in atherogenesis. Exp. Physiol. 1997, 82:297-304.
8. Carcamo J.M., Pedraza A., Borquez-Ojeda O., Golde D.W. Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation. Biochemistry 2002, 41:12995-13002.
9. Chandrasekar B., Boylston W.H., Venkatachalam K., Webster N.J., Prabhu S.D., Valente A.J. Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF-kappaB/PTEN suppression. J. Biol. Chem. 2008, 283:24889-24898.
10. Choi S.H., Hong E.S., Lim S. Clinical implications of adipocytokines and newly emerging metabolic factors with relation to insulin resistance and cardiovascular health. Front. Endocrinol. (Lausanne) 2013, 4:97.
11. Davis B.J., Xie Z., Viollet B., Zou M.H. Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 2006, 55:496-505.
12. Hardie D.G. The AMP-activated protein kinase pathway-new players upstream and downstream. J. Cell Sci. 2004, 117:5479-5487.
13. Hattori Y., Suzuki M., Hattori S., Kasai K. Vascular smooth muscle cell activation by glycated albumin (Amadori adducts). Hypertension 2002, 39:22-28.
14. Hattori Y., Suzuki K., Hattori S., Kasai K. Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension 2006, 47:1183-1188.
15. Huang S.S., Huang P.H., Chen Y.H., Chiang K.H., Chen J.W., Lin S.J. Association of adiponectin with future cardiovascular events in patients after acute myocardial infarction. J. Atheroscler. Thromb. 2010, 17:295-303.
16. Hwang Y.C., Woo Oh S., Park S.W., Park C.Y. Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans. Int. J. Obes. (Lond) 2014, 38:1207-1212.
17. Iiyama K., Hajra L., Iiyama M., Li H., DiChiara M., Medoff B.D., Cybulsky M.I. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ. Res. 1999, 85:199-207.
18. Iwai K. Diverse ubiquitin signaling in NF-kappaB activation. Trends Cell Biol. 2012, 22:355-364.
19. Jung C.H., Lee M.J., Kang Y.M., Jang J.E., Leem J., Lee Y.L., Seol S.M., Yoon H.K., Lee W.J., Park J.Y. Association of serum C1q/TNF-related protein-9 concentration with arterial stiffness in subjects with type 2 diabetes. J. Clin. Endocrinol. Metab. 2014, 99:E2477-E2484.
20. Kambara T., Ohashi K., Shibata R., Ogura Y., Maruyama S., Enomoto T., Uemura Y., Shimizu Y., Yuasa D., Matsuo K., Miyabe M., Kataoka Y., Murohara T., Ouchi N. CTRP9 protein protects against myocardial injury following ischemia-reperfusion through AMP-activated protein kinase (AMPK)-dependent mechanism. J. Biol. Chem. 2012, 287:18965-18973.
21. Kambara T., Shibata R., Ohashi K., Matsuo K., Hiramatsu-Ito M., Enomoto T., Yuasa D., Ito M., Hayakawa S., Ogawa H., Aprahamian T., Walsh K., Murohara T., Ouchi N. C1q/Tumor necrosis factor-related protein 9 protects against acute myocardial injury through an adiponectin receptor I-AMPK-dependent mechanism. Mol. Cell Biol. 2015, 35:2173-2185.
22. Kishore U., Gaboriaud C., Waters P., Shrive A.K., Greenhough T.J., Reid K.B., Sim R.B., Arlaud G.J. C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol. 2004, 25:551-561.
23. Li J., Zhang P., Li T., Liu Y., Zhu Q., Chen T., Liu T., Huang C., Zhang J., Zhang Y., Guo Y. CTRP9 enhances carotid plaque stability by reducing pro-inflammatory cytokines in macrophages. Biochem. Biophys. Res. Commun. 2015, 458:890-895.
24. Liang B., Wang X., Zhang N., Yang H., Bai R., Liu M., Bian Y., Xiao C., Yang Z. Angiotensin-(1-7) attenuates angiotensin ii-induced ICAM-1, VCAM-1, and MCP-1 expression via the MAS receptor through suppression of P38 and NF-kappaB pathways in HUVECs. Cell Physiol. Biochem. 2015, 35:2472-2482.
25. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
26. Min J.K., Kim Y.M., Kim S.W., Kwon M.C., Kong Y.Y., Hwang I.K., Won M.H., Rho J., Kwon Y.G. TNF-related activation-induced cytokine enhances leukocyte adhesiveness: induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-kappaB activation in endothelial cells. J. Immunol. 2005, 175:531-540.
27. Motoshima H., Wu X., Mahadev K., Goldstein B.J. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem. Biophys. Res. Commun. 2004, 315:264-271.
28. Musi N., Hirshman M.F., Nygren J., Svanfeldt M., Bavenholm P., Rooyackers O., Zhou G., Williamson J.M., Ljunqvist O., Efendic S., Moller D.E., Thorell A., Goodyear L.J. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 2002, 51:2074-2081.
29. Onat D., Brillon D., Colombo P.C., Schmidt A.M. Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis. Curr. Diab. Rep. 2011, 11:193-202.
30. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T., Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100:2473-2476.
31. Park S.H., Gammon S.R., Knippers J.D., Paulsen S.R., Rubink D.S., Winder W.W. Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle. J. Appl. Physiol. (1985) 2002, 92:2475-2482.
32. Schaffler A., Buechler C. CTRP family: linking immunity to metabolism. Trends Endocrinol. Metab. 2012, 23:194-204.
33. Seldin M.M., Tan S.Y., Wong G.W. Metabolic function of the CTRP family of hormones. Rev. Endocr. Metab. Disord. 2014, 15:111-123.
34. Uemura Y., Shibata R., Ohashi K., Enomoto T., Kambara T., Yamamoto T., Ogura Y., Yuasa D., Joki Y., Matsuo K., Miyabe M., Kataoka Y., Murohara T., Ouchi N. Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation. FASEB J. 2013, 27:25-33.
35. Wong G.W., Krawczyk S.A., Kitidis-Mitrokostas C., Ge G., Spooner E., Hug C., Gimeno R., Lodish H.F. Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin. FASEB J. 2009, 23:241-258.
36. Zheng Q., Yuan Y., Yi W., Lau W.B., Wang Y., Wang X., Sun Y., Lopez B.L., Christopher T.A., Peterson J.M., Wong G.W., Yu S., Yi D., Ma X.L. C1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway. Arterioscler. Thromb. Vasc. Biol. 2011, 31:2616-2623.
37. Zou M.H., Wu Y. AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function. Clin. Exp. Pharmacol. Physiol. 2008, 35:535-545.
38. Zou M.H., Kirkpatrick S.S., Davis B.J., Nelson J.S., Wiles W.G.t., Schlattner U., Neumann D., Brownlee M., Freeman M.B., Goldman M.H. Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. J. Biol. Chem. 2004, 279:43940-43951.